FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029120693> ?p ?o ?g. }

• W2029120693 endingPage "e51165" @default.
• W2029120693 startingPage "e51165" @default.
• W2029120693 abstract "Background and Aims Serum levels of γ-glutamyl-transpeptidase(γ-GT) were associated with liver disease severity and metabolic alterations, which in turn are able to affect hepatic damage. In patients with nonalcoholic fatty liver disease (NAFLD), genotype 1 chronic hepatitis C (G1CHC) and chronic hepatitis B (CHB), we assessed the link between liver fibrosis and γ-GT serum levels, and we evaluated if normal or high γ-GT serum levels affect the association between insulin resistance (IR) and severity of liver fibrosis. Methods 843 consecutive patients with chronic liver disease (CLD)(193 NAFLD, 481 G1CHC, 169 CHB) were evaluated by liver biopsy (Kleiner and Scheuer scores) and clinical and metabolic measurements. IR was diagnosed if HOMA>3. A serum γ-GT concentration of >36 IU/L in females and >61 IU/L in males was considered the threshold value for identifying high levels of γ-GT. Results By multivariate logistic regression analysis, abnormal γ-GT serum levels were independently linked to severe liver fibrosis in patients with NAFLD (OR2.711,CI1.120–6.564,p = 0.02), G1CHC (OR3.461,CI2.138–5.603,p<0.001) and CHB (OR2.778,CI1.042–7.414,p = 0.04), together with IR and liver necroinflammation, and with a negative predictive value>80%. Interestingly, among patients with high or normal γ-GT values, even if IR prevalence was significantly higher in patients with severe fibrosis compared to those without, IR remained significantly associated with severe fibrosis in patients with abnormal γ-GT values only (OR4.150,CI1.079–15.970,p = 0.03 for NAFLD; OR2.250,CI1.211–4.181,p = 0.01 for G1CHC; OR3.096,CI2.050–34.220,p = 0.01 for CHB). Conclusions In patients with CLD, IR is independently linked to liver fibrosis only in patients with abnormal γ-GT values, without differences according to liver disease etiology, and suggesting a role of γ-GT as a marker of metabolic-induced liver damage. These data could be useful for the clinical and pharmacologic management of patients with CLD." @default.
• W2029120693 created "2016-06-24" @default.
• W2029120693 creator A5013334772 @default.
• W2029120693 creator A5041520897 @default.
• W2029120693 creator A5048901003 @default.
• W2029120693 creator A5050427461 @default.
• W2029120693 creator A5066459416 @default.
• W2029120693 creator A5069060952 @default.
• W2029120693 creator A5079130912 @default.
• W2029120693 date "2012-12-05" @default.
• W2029120693 modified "2023-10-05" @default.
• W2029120693 title "Serum γ-glutamyl Transferase Levels, Insulin Resistance and Liver Fibrosis in Patients with Chronic Liver Diseases" @default.
• W2029120693 cites W1868946762 @default.
• W2029120693 cites W1917824136 @default.
• W2029120693 cites W1977756684 @default.
• W2029120693 cites W1994836578 @default.
• W2029120693 cites W1997425045 @default.
• W2029120693 cites W2002557725 @default.
• W2029120693 cites W2005013380 @default.
• W2029120693 cites W2011162537 @default.
• W2029120693 cites W2032913011 @default.
• W2029120693 cites W2036440470 @default.
• W2029120693 cites W2038050137 @default.
• W2029120693 cites W2038159864 @default.
• W2029120693 cites W2051984446 @default.
• W2029120693 cites W2054221614 @default.
• W2029120693 cites W2061699612 @default.
• W2029120693 cites W2062812115 @default.
• W2029120693 cites W2082752173 @default.
• W2029120693 cites W2087928833 @default.
• W2029120693 cites W2103002222 @default.
• W2029120693 cites W2103156933 @default.
• W2029120693 cites W2118086745 @default.
• W2029120693 cites W2118089700 @default.
• W2029120693 cites W2147208965 @default.
• W2029120693 cites W2155510029 @default.
• W2029120693 cites W2155820844 @default.
• W2029120693 cites W2155883829 @default.
• W2029120693 cites W2160234571 @default.
• W2029120693 cites W2169942469 @default.
• W2029120693 doi "https://doi.org/10.1371/journal.pone.0051165" @default.
• W2029120693 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3515567" @default.
• W2029120693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23227248" @default.
• W2029120693 hasPublicationYear "2012" @default.
• W2029120693 type Work @default.
• W2029120693 sameAs 2029120693 @default.
• W2029120693 citedByCount "30" @default.
• W2029120693 countsByYear W20291206932013 @default.
• W2029120693 countsByYear W20291206932014 @default.
• W2029120693 countsByYear W20291206932015 @default.
• W2029120693 countsByYear W20291206932016 @default.
• W2029120693 countsByYear W20291206932017 @default.
• W2029120693 countsByYear W20291206932018 @default.
• W2029120693 countsByYear W20291206932020 @default.
• W2029120693 countsByYear W20291206932021 @default.
• W2029120693 countsByYear W20291206932022 @default.
• W2029120693 countsByYear W20291206932023 @default.
• W2029120693 crossrefType "journal-article" @default.
• W2029120693 hasAuthorship W2029120693A5013334772 @default.
• W2029120693 hasAuthorship W2029120693A5041520897 @default.
• W2029120693 hasAuthorship W2029120693A5048901003 @default.
• W2029120693 hasAuthorship W2029120693A5050427461 @default.
• W2029120693 hasAuthorship W2029120693A5066459416 @default.
• W2029120693 hasAuthorship W2029120693A5069060952 @default.
• W2029120693 hasAuthorship W2029120693A5079130912 @default.
• W2029120693 hasBestOaLocation W20291206931 @default.
• W2029120693 hasConcept C126322002 @default.
• W2029120693 hasConcept C134018914 @default.
• W2029120693 hasConcept C181199279 @default.
• W2029120693 hasConcept C2775934546 @default.
• W2029120693 hasConcept C2776954865 @default.
• W2029120693 hasConcept C2777075537 @default.
• W2029120693 hasConcept C2777382497 @default.
• W2029120693 hasConcept C2777391703 @default.
• W2029120693 hasConcept C2777766500 @default.
• W2029120693 hasConcept C2778772119 @default.
• W2029120693 hasConcept C2779134260 @default.
• W2029120693 hasConcept C2779306644 @default.
• W2029120693 hasConcept C2780559512 @default.
• W2029120693 hasConcept C2781278919 @default.
• W2029120693 hasConcept C55493867 @default.
• W2029120693 hasConcept C71924100 @default.
• W2029120693 hasConcept C86803240 @default.
• W2029120693 hasConcept C90924648 @default.
• W2029120693 hasConceptScore W2029120693C126322002 @default.
• W2029120693 hasConceptScore W2029120693C134018914 @default.
• W2029120693 hasConceptScore W2029120693C181199279 @default.
• W2029120693 hasConceptScore W2029120693C2775934546 @default.
• W2029120693 hasConceptScore W2029120693C2776954865 @default.
• W2029120693 hasConceptScore W2029120693C2777075537 @default.
• W2029120693 hasConceptScore W2029120693C2777382497 @default.
• W2029120693 hasConceptScore W2029120693C2777391703 @default.
• W2029120693 hasConceptScore W2029120693C2777766500 @default.
• W2029120693 hasConceptScore W2029120693C2778772119 @default.
• W2029120693 hasConceptScore W2029120693C2779134260 @default.
• W2029120693 hasConceptScore W2029120693C2779306644 @default.
• W2029120693 hasConceptScore W2029120693C2780559512 @default.
• W2029120693 hasConceptScore W2029120693C2781278919 @default.

• next